ChelohartЧелохарт
A peptide mixture from calf or pig heart tissue, studied in heart-cell cultures and a small human exercise-test report.
What the studies found
Lab research · 2015
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
Findings for this preparation
Chelohart was among the calf-tissue preparations tested in corresponding rat organotypic cultures. The abstract reports tissue-growth and marker changes across the preparations; it does not provide a separate numerical effect estimate for this preparation.
Study notes · methods, sources and limitations
Participants or model Organotypic tissue cultures from young and old rats
Important limitations
- Tissue-culture growth is not organ regeneration in patients; equivalence to current branded products is unverified. Full methods, reporting completeness and independent replication remain to be appraised.
Advances in gerontology = Uspekhi gerontologii · PMID 26390619 · Original journal report
Comparison in people · 2011
Chelohart: clinical report on a tissue-derived preparation
- Angina during cycle ergometry
- 36.4% with Chelohart versus 50% with conventional care. Shared baseline 68.8%.The report marks p < 0.05 versus conventional care.
- Achieving submaximal heart rate
- 54.5% versus 40%. Shared baseline 21.9%.The report marks p < 0.05 versus conventional care.
- Threshold exercise power
- 119.3 ± 4.6 versus 115.2 ± 5.4 in the report’s stated units.The text reports a nonsignificant between-group difference.
Angina occurred during exercise testing in 36.4% with Chelohart and 50% with conventional care. Threshold exercise power did not differ significantly between groups.
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
Study notes · methods, sources and limitations
Participants or model 32 angina patients: 22 adjunctive Chelohart; 10 controls.
Design 22 adults received one Chelohart capsule twice daily with meals for 30 days alongside conventional care. Ten controls received conventional therapy alone.
Important limitations
- A larger numerical improvement is not necessarily a significant between-group difference. Allocation, blinding and complete adverse-event collection need verification from original study documentation. Commercially reproduced institute report; independent peer review and independent replication are not established by this document. Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.
- The report leaves allocation and masking unspecified and gives a shared baseline for the exercise table.
Institute clinical report (commercial reproduction); 2011 study/report date, not website publication date · Institute report — commercial reproduction
About Chelohart
Identity / background source ↗
Research background
Chelohart is a heart-derived peptide preparation. A 32-person Medical Center report measured exercise-test outcomes in people with angina.
- Compound class
- Tissue-derived peptide preparation
- Research collection
- Peptide bioregulation · editorial grouping
- Institutions in linked studies
- Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
32 angina patients: 22 adjunctive Chelohart; 10 controls.
Study methods
Small comparative institute report; allocation, blinding and outcome interpretation require caution
Independent replication
New citations are not automatically independent replication; shared programs and translated reports require cohort checks
Source access
New indexed primary abstracts and/or report reproductions linked; review depth shown per source
Safety evidence
Reported tolerability is not proof of safety; uncommon harms and long-term outcomes remain unresolved
Open a topic for the evidence assessment.
Findings by study
Tissue-preparation reports: comparisons, source limits and remaining gaps ↗
Lab research · 2015
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
Chelohart was among the calf-tissue preparations tested in corresponding rat organotypic cultures. The abstract reports tissue-growth and marker changes across the preparations; it does not provide a separate numerical effect estimate for this preparation.
Study notes and original source
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
· Original journal report
Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN · Advances in gerontology = Uspekhi gerontologii · PMID 26390619
Calf-tissue preparations, including Ventvil, stimulated corresponding tissue-culture growth with changes in proliferation-related markers.
- Population / setting
- Organotypic tissue cultures from young and old rats
- Source reviewed
- Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
- Tissue-culture growth is not organ regeneration in patients; equivalence to current branded products is unverified.
- Full methods, reporting completeness and independent replication remain to be appraised.
Reviewed 2026-10-05.
Comparison in people · 2011
Chelohart: clinical report on a tissue-derived preparation
Angina occurred during exercise testing in 36.4% with Chelohart and 50% with conventional care. Threshold exercise power did not differ significantly between groups.
Angina during cycle ergometry · 36.4% with Chelohart versus 50% with conventional care. Shared baseline 68.8%. · The report marks p < 0.05 versus conventional care.
Study notes and original source
Chelohart: clinical report on a tissue-derived preparation
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
Tissue-derived mixture / named preparation · Institute report — commercial reproduction
St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution) · Institute clinical report (commercial reproduction); 2011 study/report date, not website publication date
Angina occurred during exercise testing in 36.4% with Chelohart and 50% with conventional care. Threshold exercise power did not differ significantly between groups.
Results and tables
Reported findings and study design
22 adults received one Chelohart capsule twice daily with meals for 30 days alongside conventional care. Ten controls received conventional therapy alone.
Population or model 32 angina patients: 22 adjunctive Chelohart; 10 controls.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Angina during cycle ergometry | 36.4% with Chelohart versus 50% with conventional care. Shared baseline 68.8%. | The report marks p < 0.05 versus conventional care. |
| Achieving submaximal heart rate | 54.5% versus 40%. Shared baseline 21.9%. | The report marks p < 0.05 versus conventional care. |
| Threshold exercise power | 119.3 ± 4.6 versus 115.2 ± 5.4 in the report’s stated units. | The text reports a nonsignificant between-group difference. |
The report leaves allocation and masking unspecified and gives a shared baseline for the exercise table.
Source for these results ↗ · Reviewed 2026-11-16
- Population / setting
- 32 angina patients: 22 adjunctive Chelohart; 10 controls.
- Source reviewed
- Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.
Study limitations
- A larger numerical improvement is not necessarily a significant between-group difference. Allocation, blinding and complete adverse-event collection need verification from original study documentation.
- Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
- Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.
Reviewed 2026-11-16.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗